Clinical trial

Expanded Access to Diagnostic Imaging for Staging of Recurrent Prostate Cancer

NCT02260817

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2014-10-01

PhasePHASE3

Study timeline

Study start (actual)2014-10-01Date precision: month

Registry last updated2019-12-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Prostate Cancerunresolved

Interventions

11C-choline InjectionDRUG

Sponsors & collaborators

Global Isotopes, LLC d/b/a Zevacor Molecularlead sponsor

Mapped research locations

DecaturIllinois, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02260817 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.